Utilización de medicamentos hipolipemiantes en un establecimiento farmacéutico privado, marzo 2018 - febrero 2019
No Thumbnail Available
Date
2021
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El presente informe tiene por objetivo determinar la utilización de medicamentos hipolipemiantes en un establecimiento farmacéutico de Trujillo, en el período marzo 2018- febrero 2019. Los datos fueron extraídos de la base de datos del sistema de ventas Enterprise- Software de Boticas Multhipharma. Los resultados obtenidos fueron: atorvastatina de 20 y 40mg, y gemfibrozilo 600mg, son las concentraciones de medicamentos hipolipemiantes con mayor utilización con un 47,48%, 15,84% y 10,73%, respectivamente. En terapia de combinación se obtuvo que Vasotenazol EZ 20/10, Ezator 10mg/20 y Simibe 10mg/20mg, fueron las concentraciones de medicamentos hipolipemiantes de mayor utilización con un 67,55%, 12,24 y 9,18 %. El expendio de medicamentos hipolipemiantes en la denominación genérica coberturó el 82.20%. Así mismo, el más utilizado por su menor gasto fue la atorvastatina de 20mg cuya frecuencia fue de 47,48%, obtuvo un gasto total anual de S/. 1.120,92 nuevos soles frente a la atorvastatina de 40mg con una frecuencia de 15,84%, con un gasto total anual de 1250,63 nuevos soles y atorvastatina de 10 mg con frecuencia de 10,73% cuyo gasto anual fue de 179,25 nuevos soles
ABSTRACT The objective of this report is to determine the use of lipid-lowering drugs in a private establishment in Trujillo, in the period March 2018- February 2019. The data was extracted from the database of the Enterprise-Software sales system of Boticas Multhipharma. When analyzing and processing them, it was obtained that the concentrations with the highest use were atorvastine of 20 mg with a frequency of 47.48%, atorvastatin of 40mg with a frequency of 15.84% and gemfibrozil of 600 mg with a frequency of 10.73%, concluding that atorvastatin of 20 mg is the most widely used. In combination therapy it was obtained that Vasotenazole ez 20/10 mg had a frequency of 67.55%, Ezator 10mg / 20 mg a frequency of 12.24% and Simibe 10mg / 20mg a frequency of 9.18 mg, concluding that Vasotenazole ez 20 / 10mg is the most widely used. Among the generic or multifunctional brand drugs, the laboratories with the highest frequency of use were: Generic Portugal with 82.20%, Roemmers 7.52% and Cardio 5.45%, concluding that Generic Portugal Laboratory had the highest frequency. Also, the most used for its lower cost was atorvastatin 20mg whose frequency was 47.48%, it obtained a total annual cost was S /. 1,120.92 nuevos soles compared to atorvastatin 40mg with a frequency of 15.84%, with a total annual expenditure of 1,250.63 nuevos soles and atorvastatin 10 mg with a frequency of 10.73% whose annual expenditure was 179, 25 new soles.
ABSTRACT The objective of this report is to determine the use of lipid-lowering drugs in a private establishment in Trujillo, in the period March 2018- February 2019. The data was extracted from the database of the Enterprise-Software sales system of Boticas Multhipharma. When analyzing and processing them, it was obtained that the concentrations with the highest use were atorvastine of 20 mg with a frequency of 47.48%, atorvastatin of 40mg with a frequency of 15.84% and gemfibrozil of 600 mg with a frequency of 10.73%, concluding that atorvastatin of 20 mg is the most widely used. In combination therapy it was obtained that Vasotenazole ez 20/10 mg had a frequency of 67.55%, Ezator 10mg / 20 mg a frequency of 12.24% and Simibe 10mg / 20mg a frequency of 9.18 mg, concluding that Vasotenazole ez 20 / 10mg is the most widely used. Among the generic or multifunctional brand drugs, the laboratories with the highest frequency of use were: Generic Portugal with 82.20%, Roemmers 7.52% and Cardio 5.45%, concluding that Generic Portugal Laboratory had the highest frequency. Also, the most used for its lower cost was atorvastatin 20mg whose frequency was 47.48%, it obtained a total annual cost was S /. 1,120.92 nuevos soles compared to atorvastatin 40mg with a frequency of 15.84%, with a total annual expenditure of 1,250.63 nuevos soles and atorvastatin 10 mg with a frequency of 10.73% whose annual expenditure was 179, 25 new soles.
Description
Keywords
Medicamento hipolipemiante. Estudio. Utilización de medicamentos